Rinoo Shah, MD
Physical Medicine & Rehabilitation · Dallas, TXNPI 1477557437
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,625 of the $6,603 with a category attached, or 85.2%. 22 manufacturers reported payments, led by Medtronic at 39.1% of the total. Reporting peaked in 2023 at $2,243 and has fallen 51.3% since, to $1,093 in 2025. Among physical medicine & rehabilitation clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $26.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$1K
- Spinal Simplicity, LLC$577
- Genesys Orthopedics Systems, L.L.C.$547
- Boston Scientific$373
- Stryker$178
- plus $1K from 16 others
What the payments were for
- Travel & lodging$90314%
- Food & beverage$5,62585%
- Education$601%
- Gifts$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 75 | $2,581 |
| Abbott | 57 | $1,192 |
| Spinal Simplicity, LLC | 76 | $577 |
| Genesys Orthopedics Systems, L.L.C. | 5 | $547 |
| Boston Scientific | 6 | $373 |
| Stryker | 2 | $178 |
| Tersera Therapeutics LLC | 5 | $156 |
| Nevro Corp. | 1 | $139 |
| AbbVie | 2 | $136 |
| MML US, Inc. | 2 | $130 |
| Avanos Medical | 1 | $107 |
| Nalu Medical, Inc. | 4 | $89 |
| SPR Therapeutics, Inc | 1 | $80 |
| Scilex Pharmaceuticals Inc. | 3 | $65 |
| Convatec Inc. | 1 | $63 |
| Baudax Bio Inc. | 1 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Novartis | 2 | $29 |
| Relievant Medsystems, Inc. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Amgen | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$470
- SACROILIAC JOINT FUSION SYSTEM$352
- INTELLIS ADAPTIVESTIM$336
- SUPERION$259
- SYNCHROMED$171
- SPINEJACK$166
- INTELLIS$157
- VANTA ADAPTIVESTIM$145
- Senza Spinal Cord Stimulation System$139
- BOTOX$124
- GENERATOR$107
- OSTEOCOOL RF ABLATION$105
- ReActiv8$102
How this compares
$6,603 in reported general payments places this provider in the 90th percentile of 651 physical medicine & rehabilitation providers in Texas.
See all physical medicine & rehabilitation providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,330 | $41,642 |
| Nalbuphine Hcl | 103 | $17,535 |
| NucyntaTapentadol Hcl | 11 | $15,283 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 333 | $13,206 |
| BelbucaBuprenorphine Hcl | 16 | $12,870 |
| Pregabalin | 227 | $9,858 |
| Piroxicam | 15 | $8,550 |
| MovantikNaloxegol Oxalate | 20 | $8,172 |
| Lidocaine | 52 | $5,611 |
| Calcipotriene | 15 | $4,929 |
| Gabapentin | 441 | $4,666 |
| Fentanyl | 44 | $4,076 |
| Methocarbamol | 165 | $3,015 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 113 | $2,515 |
| Duloxetine Hcl | 119 | $1,945 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Belbuca | $19 | $28,15227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 651 physical medicine & rehabilitation providers in Texas.
Other physical medicine & rehabilitation in Dallas
- Gireesh ShardaDallas$172K
- Fatma GulDallas$21K
- Priya ChittaDallas$15K
- Nikesh PatelDallas$14K
- Surendra BarshikarDallas$11K
- Gerard FranciscoHouston$364K
- Jose UrquidezAustin$332K
- Suzanne ManziHouston$143K
- Cindy IvanhoeHouston$111K
- Chad McNeilTyler$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.